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In the embryonic visual system, EphA receptors are expressed on both temporal and nasal retinal ganglion cell axons. Only
the temporal axons, however, are sensitive to the low concentrations of ephrin-A ligands found in the anterior optic tectum.
The poor responsiveness of nasal axons to ephrin-A ligands, which allows them to traverse the anterior tectum and reach
their targets in the posterior tectum, has been attributed to constitutive activation of the EphA4 receptor expressed in these
axons. EphA4 is highly expressed throughout the retina, but is preferentially phosphorylated on tyrosine (activated) in nasal
retina. In a screen for EphA4 ligands expressed in chicken embryonic retina, we have identified a novel ephrin, ephrin-A6.
Like ephrin-A5, ephrin-A6 has high affinity for EphA4 and activates this receptor in cultured retinal cells. In the embryonic
day 8 (E8) chicken visual system, ephrin-A6 is predominantly expressed in the nasal retina and ephrin-A5 in the posterior
tectum. Thus, ephrin-A6 has the properties of a ligand that activates the EphA4 receptor in nasal retinal cells. Ephrin-A6
binds with high affinity to several other EphA receptors as well and causes growth cone collapse in retinal explants,
demonstrating that it can elicit biological responses in retinal neurons. Ephrin-A6 expression is high at E6 and E8, when
retinal axons grow to their tectal targets, and gradually declines at later developmental stages. The asymmetric distribution
of ephrin-A6 in retinal cells, and the time course of its expression, suggest that this new ephrin plays a role in the
establishment of visual system topography. © 2001 Academic Press





Eph receptor tyrosine kinases and their ephrin ligands are
required for the topographic organization of the embryonic
visual system (Feldheim et al., 2000, 1998; Frisen et al.,
1998). The EphA3 receptor is expressed in an increasing
nasal to temporal gradient in the developing axons of
chicken retinal ganglion cells (Cheng and Flanagan, 1994)
and the ligands ephrin-A2 and ephrin-A5 are expressed in
increasing anterior to posterior gradients in the target of
retinal ganglion cell axons, the optic tectum (superior
colliculus in the mouse) (Cheng and Flanagan, 1994; Dre-
scher et al., 1995; Feldheim et al., 1998; Frisen et al., 1998;
Nakamoto et al., 1996). According to one model, repulsion
by gradually increasing levels of ephrin-A ligands prevents
the growth of temporal axons to the posterior tectum
(Drescher et al., 1995; Nakamoto et al., 1996). According to
another model, temporal axons expressing EphA receptors
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74initially extend into the posterior tectum, where interac-
tion with ephrin-A2 and ephrin-A5 subsequently causes
their withdrawal or degeneration (Feldheim et al., 1998;
Frisen et al., 1998; Gao et al., 1999; Roskies et al., 1995). A
topographic map is generated because the concentration of
ephrin required for axon repulsion, or elimination, is in-
versely proportional to the EphA receptor concentration on
the temporal axons (Nakamoto et al., 1996). Thus, tectal
regions with high ephrin-A2 and ephrin-A5 expression are
ultimately devoid of axons with high EphA receptor expres-
sion.
The regulation of retinotectal topography by EphA recep-
tors is, however, more complex. Several EphA receptors in
addition to EphA3 are present in retinal cells with different
spatial distributions (Cheng et al., 1995; Connor et al.,
998; Feldheim et al., 2000; Marcus et al., 1996; Monschau
t al., 1997; Sefton et al., 1997; Zhang et al., 1996). We have
reviously reported that the EphA4 receptor, for example, is
ighly expressed in the embryonic retina and optic nerve
Holash and Pasquale, 1995). Although uniformly expressed
n different sectors of the retina at embryonic day 8 (E8),
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75Ephrin-A6, A New Ligand for EphA ReceptorsEphA4 is asymmetrically phosphorylated on tyrosine, with
higher phosphorylation levels in the nasal than the tempo-
ral retina (Connor et al., 1998). This tyrosine phosphoryla-
tion of EphA4 may have functional significance for the
topographic organization of the retinotectal projection by
attenuating the repulsive effects of ephrin-A ligands en-
countered by nasal retinal axons (Hornberger et al., 1999;
Rosentreter et al., 1998). This effect could explain the
ability of nasal axons to reach regions of the optic tectum
that contain substantial levels of ephrin-A2 and ephrin-A5
even though these axons express EphA receptors (Dutting et
al., 1999; Feldheim et al., 2000; Hornberger et al., 1999).
The uneven phosphorylation pattern of EphA4 suggests
that this receptor is activated by a ligand present in the E8
nasal retina (Connor et al., 1998). We initially thought that
this ligand may be ephrin-A5 (Connor et al., 1998) because
ephrin-A5 binds EphA4 with high affinity (Monschau et al.,
1997) and is present at higher levels in the nasal than the
temporal retina (Connor et al., 1998; Dutting et al., 1999;
Hornberger et al., 1999). We have found, however, that
ephrin-A5 protein is expressed at low levels in the chicken
embryonic retina, suggesting that another ephrin activates
EphA4 in the nasal retina. We have, therefore, used RT-PCR
with degenerate primers to identify the ephrins expressed in
the chicken embryonic retina. One of the amplified prod-
ucts encodes a novel ephrin, which we have designated
ephrin-A6. We demonstrate here that ephrin-A6 has the
properties expected for the main ligand that activates
EphA4 in nasal retinal cells.
MATERIALS AND METHODS
Reverse Transcription and Polymerase Chain
Reaction
For polymerase chain reaction (PCR) with degenerate primers,
mRNA was prepared from E8 chicken retina using the Micro-
FastTrack Kit (Invitrogen) and reverse transcription was performed
using the cDNA cycle kit (Invitrogen) with random primers
according to the instructions of the manufacturer. PCR was then
carried out with degenerate primers corresponding to sequences
conserved in the A-ephrins or the B-ephrins. A-ephrins were
amplified using two sense degenerate primers, GTCT(A/T)CT-
GGAACAG(T/C) AG(T/C)AA(T/C)CC or GTCT(A/T)CTGGAAC-
AG(C/T)TC(G/A/T/C)AA(C/T)CC, and one anti-sense degener-
ate primer, GG(A/T)GT(G/A)AAG(A/C)G(T/C)TG(G/A)AA(T/C)TT-
(T/C)TC. B-ephrins were amplified using the sense primer
CGGATCCAC(G/A/T/C)AT(A/T/C)AA(G/A)TT(T/C)CA(G/A)GA-
(G/A)T (introduced BamHI site in italics) and the antisense primer
GGAATTCA(G/A/T/C)AC(T/C)TT(G/A)TA(G/A)TA(G/A/T)AT-
(G/A)TT (introduced EcoRI site in italics). PCR amplifications were
performed using five cycles with annealing at 37°C followed by 30
cycles with annealing at 45°C, and Taq polymerase was added only
after the initial cycle of denaturation at 95°C. Bands of the appropriate
size were gel purified and reamplified either with the same primers
(B-ephrin primers) or with longer primers that included an EcoRI site
A-ephrin primers), subcloned into pGEX-4T-1 vector (Pharmacia) or
T7Blue vector (Novagen), and sequenced.For PCR with ephrin-A6 specific primers, reverse transcription
Copyright © 2001 by Academic Press. All rightwas performed either with E8 dorsal retina mRNA and random
primers or with E8 ventral retina mRNA and the ephrin-A6 specific
anti-sense primer GGGATCCTCACTACCGGGGGTTAAACCG
(Bam A6, containing an introduced BamHI site, in italics). A first
PCR amplification was carried out with the sense primer
CGCTAGCACGCCGCCACGGCGTCTACTGG (Nhe A6, con-
taining an NheI site, in italics) and the Bam A6 antisense primer.
Two bands of approximately 400 and 1000 bp were obtained from
amplification of the dorsal retina cDNA, with the larger band being
more prominent. Only the 400-bp band was detectable in the
amplification of the ventral retina mRNA. The two PCR fragments
were reamplified using (1) the Nhe A6 sense primer and the
antisense primer GAAGGGTTTATTACACTCCC (39 A6–2),
hich yielded the same fragment (comprising nucleotides 123–285,
ig. 2B) from amplification of both bands; (2) the sense primer
AAGGGTTTATTACACTCCC (59A6–2) and the 39 A6–2 anti-
ense primer, which yielded the same fragment (comprising nucle-
tides 21–285) from amplification of both bands; (3) the 59 A6–2
ense primer and the Bam A6 antisense primer, which yielded a
ragment comprising nucleotides 123–956 of ephrin-A6a from
mplification of the larger band and a fragment comprising nucle-
tides 123–524 of ephrin-A6b (or the corresponding regions of
ephrin-A6g, d, or e) from amplification of the smaller band.
Rapid Amplification of cDNA Ends (RACE)
E8 chicken retina mRNA was isolated using the Micro-
FastTrack kit and used for 59 and 39 RACE using the 59 RACE
ystem Kit (GibcoBRL) according to the instructions of the manu-
acturer. For 59 RACE, cDNA synthesis was primed using the
antisense primer GAACGGGGACGAACGGAGCG (39 A6–1).
Terminal deoxynucleotidyl transferase was used to add a ho-
mopolymeric dC tail to the 39 end of the purified single-stranded
cDNA. The dC-tailed cDNA was then amplified by PCR with the
59 RACE Abridged Anchor Primer (GibcoBRL) containing a 39
sequence complementary to the polyC tail and the 39 A6–1 primer
and reamplified using the Abridged Universal Amplification
Primer (AUAP) (GibcoBRL) and the nested antisense primer 39
A6–2. PCR products were digested with Sal I (in the AUAP) and
PstI (in the amplified A6 product), cloned into Sal I and PstI
digested pBluescript SK vector, and sequenced. For 39 RACE, cDNA
synthesis was primed using the oligo-dT 39 RACE Adapter Primer
(GibcoBRL), which contains the sequence of the AUAP. The cDNA
was then amplified using the sense primer CCAGGTTCCTGCAG-
GACGAT (59 A6–3) and the AUAP and reamplified using the
nested sense primer GAGAGCTTCACGCTGTTCAT (59 A6–4)
and the AUAP. PCR products were digested with SpeI (in the
AUAP) and NarI (in the amplified A6 product), cloned into SpeI and
sp106 digested pBluescript SK vector, and sequenced.
Fc and AP Chimeras
The sequences encoding the extracellular domains of chicken
ephrin-A5 (amino acids 21–208) (Drescher et al., 1995), ephrin-A6
(amino acids 21–184), EphA3 (amino acids 22–540) (Sajjadi et al.,
1991), and EphA4 (amino acids 19–547) (Ohta et al., 1996) were
amplified by PCR with specific primers containing a NheI restric-
tion site (sense primer) and a BamHI restriction site (antisense
primer). The amplified products were cloned into a NheI–BamHI
digested pcDNA3 vector containing the sequences encoding the
signal peptide of CD5 (to the 59 end of the NheI site) and the Fc
portion of human IgG1 (to the 39 end of the BamHI site), as










































76 Menzel et al.previously described (Shao et al., 1994), and verified by sequencing.
he EphA3 Fc and EphA4 Fc expression plasmids were transiently
ransfected into COS cells using Superfect transfection reagent
Quiagen). Cell culture supernatants containing the fusion proteins
ere centrifuged at 4000g to eliminate cell debris and stored frozen
at 220°C. The ephrin-A5 Fc and ephrin-A6 Fc expression plasmids
were stably transfected into 293T cells. Recombinant ephrin-A5
and ephrin-A6 Fc fusion proteins were purified from cell-culture
supernatants using Affi-Gel protein A (Bio-Rad) as previously
described (Shao et al., 1994) and stored frozen in aliquots in PBS
containing 1 mM CaCl2.
To produce the alkaline phosphatase (AP) fusion constructs, the
equences of the extracellular domains of ephrin-A5 (amino acids
1–208) and ephrin-A6 (amino acids 21–184) were amplified by
CR from the corresponding Fc vectors together with the sequence
ncoding the CD5 signal peptide. Primers used for amplification
ere T7 (sense, to pcDNA3 sequences) and either the ephrin-A5
ntisense primer TGGGAGATCTCGGTGTCTGTGCCGCG (in-
roduced Bgl II site in italics) or the ephrin-A6 antisense primer
CGTAGATCTCGGGATCGGAGCGGCGTC (introduced Bgl II
ite in italics). Amplified products were digested with HindIII (in
cDNA3) and Bgl II and cloned into similarly digested APtag2
ector (Cheng et al., 1995). Partial restriction digests were used for
phrin-A5, which contains an internal HindIII site. After sequence
erification, the expression plasmids were transiently transfected
nto 293T cells. Cell culture supernatants containing the AP fusion
roteins were centrifuged at 4000g to eliminate cell debris, supple-
ented with Hepes buffer pH 7.5 to 20 mM and NaN3 to 0.02%,
nd stored frozen at 220°C.
Antibodies
Anti-ephrin-A5 and anti-ephrin-A6 antibodies were prepared by
injecting into rabbits the corresponding Fc fusion proteins. The
immune serum was affinity-purified on columns prepared by
coupling ephrin-A5 Fc or ephrin-A6 Fc to AffiGel-10 (Bio-Rad).
Anti-Fc antibodies were then absorbed out by passing the affinity-
purified antibodies on a human Fc column (Cappel). The anti-
EphA3, EphA4, EphB2, and EphB5 antibodies have been described
previously (Holash and Pasquale, 1995; Soans et al., 1994, 1996).
The PY20 monoclonal antibody to phosphotyrosine, conjugated to
peroxidase, was from Transduction Laboratories. Affinity-purified
anti-human Fc antibody was from Cappel and antialkaline phos-
phatase polyclonal antibody from GenHunter Corporation.
Immunohistochemistry and Whole Mounts
For immunohistochemistry, E8 chicken heads were fixed over-
night in 4% paraformaldehyde in PBS and cryoprotected in 25%
sucrose in PBS. Vertical frozen sections of E8 chicken heads were
labeled with anti-ephrin-A5 or anti-ephrin-A6 antibodies as indi-
cated. Immunoperoxidase labeling was with a Vectastain Elite ABC
kit (Vector Laboratories).
For whole mounts, E3 embryos were fixed in 4% paraformalde-
hyde in PBS for 2 h at room temperature, rinsed in HBS/Triton/BSA
(150 mM NaCl, 20 mM Hepes buffer, pH 7.4, 0.1% Triton X-100,
0.5 mg/ml BSA), incubated for 2 h with 0.5 ml cell culture super-
natant containing ephrin-A6 AP and 0.1% Triton X-100, washed
6 3 10 min in HBS/Triton/BSA, heat inactivated at 65°C for 20 min,
equilibrated in AP buffer (100 mM NaCl, 100 mM Tris, pH 9.5, 5 mM
MgCl2, 0.1% Triton X-100) for 20 min at room temperature, andnally incubated with substrate (0.17 mg/ml BCIP, 0.33 NBT in AP
Copyright © 2001 by Academic Press. All rightuffer). When the desired labeling intensity was achieved, the
mbryos were rinsed in PBS to stop color development.
Retinal Cultures
Dissociated retinal cells were prepared as described in Holash et
al. (1997) from E7 chicken retinas. After 1 h in cell culture medium
containing 10% serum, the cells were cultured overnight in me-
dium with 0.5% serum. Cultures were then treated with 10 mg/ml
phrin-A5 Fc or ephrin-A6 Fc for 15 min, before collecting in RIPA
uffer for immunoprecipitation with anti-Eph receptor antibodies.
Immunoprecipitation and Immunoblotting
Immunoprecipitations were performed as described (Holash et
al., 1997). For pull-down experiments with Fc fusion proteins, 10
mg of the Fc portion of human IgG1 (Fc), ephrin-B2 Fc, ephrin-A5 Fc,
and ephrin-A6 Fc were bound to StaphA (Boehringer Mannheim)
and then incubated with E8 chicken retina extracts in 1% Brij 96
buffer as described (Zisch et al., 1997). The proteins that remained
bound to the StaphA–Fc complexes were separated by SDS–PAGE
and probed by immunoblotting.
For immunoblotting with anti-Eph receptor or anti-ephrin anti-
bodies, filters were blocked for 1 to 16 h in 3% BSA in TBS
(Tris-hydroxyethyl aminoethane-buffered saline) or 0.2% nonfat
dry milk in PBS and then incubated for approximately 4 h at room
temperature, or overnight at 4°C, with 2–3 mg/ml antibody. After
several washes, the filters were incubated with 0.2 mg/ml protein-A
eroxidase (Sigma) in TBS containing 3% BSA for 1 h. Peroxidase-
onjugated anti-phosphotyrosine antibody (0.05 mg/ml in 3% BSA)
was used to detect tyrosine phosphorylation. The filters were then
washed and developed using enhanced chemiluminescence re-
agents (Amersham).
Equilibrium Binding Experiments
High-binding 96-well ELISA plates (Corning) were coated over-
night at 4°C with 100 ml of a 30 mg/ml anti-human Fc antibody
solution in PBS. After rinsing and blocking with 3% BSA for 1 h,
the wells were incubated on a moving platform at room tempera-
ture for 2 h with 100 ml PBS, 1mM CaCl2 containing 0.25–1 mg/ml
Eph receptor Fc (R&D Systems) or 100-ml cell culture supernatants
ontaining chicken EphA3 Fc or EphA4 Fc. The wells were then
insed and incubated for 3 h at room temperature with 200-ml cell
culture supernatants containing ephrin-A5 or ephrin-A6 AP (at the
lower concentrations, the AP solution was replaced with a second
aliquot after 1.5 h to avoid possible ligand depletion). After wash-
ing, 225 ml of 0.012 M para-nitrophenylphosphate was added and
incubated for 20 min at 37°C. OD405 was measured using an ELISA
late reader. Measurements of bound ligand AP were carried out in
uplicate. The concentration of the ephrin-A5 and ephrin-A6 AP
usion proteins, and their integrity, were determined by immuno-
lotting the ephrin AP supernatants with anti-alkaline phosphatase
ntibody and comparing with a purified alkaline phosphatase
tandard (GenHunter) by densitometric analysis. The activities of
he ephrin-A5 AP and ephrin-A6 AP supernatants were also deter-
ined after heating for 10 min at 65°C (Cheng and Flanagan, 1994;
lanagan and Leder, 1990). The specific activity of the ephrin-AP
usion proteins was approximately 125 U/mg protein (Berger et al.,
988). KD values were calculated directly from the binding curves
by nonlinear regression analysis using an hyperbolic one site
binding equation (GraphPad Prism). Final KD values are averages of
the values obtained in several experiments.













77Ephrin-A6, A New Ligand for EphA ReceptorsGrowth Cone Collapse Experiments
Explants dissected from E6 chicken retinas were cultured on
polylysine (200 mg/ml) and laminin (20 mg/ml) -coated glass cover-
slips for 24 h in 1 ml of F12-DMEM medium containing 10% FBS
and 0.4% methylcellulose. Three hours before adding Fc proteins,
the medium was exchanged to 0.5 ml medium without methylcel-
lulose. Ephrin-A6 Fc and human Fc were cross-linked by a 30 min
incubation with a 1/10 concentration of anti-Fc antibodies and
added to the explant cultures (0.5 ml/well, in culture medium
equilibrated with CO2) at 1 mg/ml final concentration. After 30 min
he cultures were fixed by adding 2% cold glutaraldehyde and then
ounted in PBS–glycerol. For quantitative analysis about 80
rowth cones were scored for each explant, and experiments were
epeated three times. Growth cones were observed under phase
ontrast optics and pictures were taken with a SPOT CCD camera.
rowth cones with no lamellipodia or filopodia remaining at the
ip of the neurite were scored as collapsed.
RESULTS
Ephrin-A5 Protein Expression Is High in the
Posterior Optic Tectum and Low in the Retina
at Embryonic Day 8
We previously detected higher levels of ephrin-A5 mRNA
in the chicken nasal retina compared to the temporal retina
at embryonic day 8 (E8) (Connor et al., 1998). To determine
whether ephrin-A5 is the ligand that causes EphA4 tyrosine
phosphorylation in the E8 nasal retina, we examined the
expression of ephrin-A5 at the protein level. While both
immunohistochemistry (Fig. 1A) and immunoblotting (Fig.
1B) experiments revealed the expected high expression of
ephrin-A5 in the posterior optic tectum (Drescher et al.,
1995; Monschau et al., 1997), ephrin-A5 protein expression
in the nasal retina appeared to be very low. This pattern of
ephrin-A5 protein expression suggested that another ligand
for EphA4 must be highly expressed in the E8 nasal retina.
RT-PCR Approach to Identify Candidate EphA4
Ligands Expressed in the Nasal Retina
EphA4, like other EphA receptors, can be activated by
several A-ephrins (Eph Nomenclature Committee, 1997). In
addition, EphA4 has substantial affinity for some B-ephrins.
We used an RT-PCR approach to search for candidate
EphA4 ligands expressed in the E8 chicken retina (Fig. 2A)
because this approach can identify known as well as un-
known ephrins. Degenerate primers designed to amplify
B-ephrins yielded ephrin-B1 and ephrin-B2. These B-ephrins
are concentrated in the dorsal rather than the nasal retina
(Holash et al., 1997; Marcus et al., 1996) and therefore are
not good candidates as ligands that activate EphA4 in the
nasal retina. Degenerate primers designed to amplify
A-ephrins yielded ephrin-A2, ephrin-A5, and a cDNA en-
coding an ephrin fragment not closely related to previously
known ones. Of the A-ephrins amplified, ephrin-A2 does
not appear to be a good candidate as the main ligand
activating EphA4 in the nasal retina because it binds poorly
Copyright © 2001 by Academic Press. All righto EphA4 (Monschau et al., 1997). Ephrin-A5, as shown
bove, is poorly expressed in the E8 retina and is therefore
nlikely to cause substantial activation of EphA4. Thus, we
ocused our efforts on the further characterization of the
utative new ephrin identified.
Cloning of Ephrin-A6
Using 59 RACE we obtained the sequence encoding the
FIG. 1. Ephrin-A5 protein is expressed at lower levels in the E8
chicken optic tectum than in the retina. (A) Immunoperoxidase
labeling shows high expression of ephrin-A5 in the posterior optic
tectum (pt) and not in the anterior tectum (at) or the retina. The
section was lightly counterstained with hematoxylin (blue). nr,
nasal retina; tr, temporal retina; of, optic fissure, which separates
nasal and temporal retina. (B) Immunoblotting shows high expres-
sion of ephrin-A5 in the posterior optic tectum and not in the
anterior tectum or the retina. Ephrin-A5 was immunoprecipitated
with specific antibodies from the tissues indicated and, after
separation by SDS–PAGE, the immunoprecipitates were probed
with anti-ephrin-A5 antibodies. The position of ephrin-A5 is indi-
cated by the arrow; the positions of molecular weight standards, in
Kd, are indicated at left.amino-terminal part of the new ephrin, except for the




78 Menzel et al.FIG. 2. Ephrin-A6 is a new ephrin ligand. (A) RT-PCR with degenerate primers to identify ephrins present in E8 chicken retina. The amino
acid sequences corresponding to the degenerate primers are indicated. (B) DNA and amino acid sequence of ephrin-A6 and its variant forms.
Ephrin-A6a has 12 hydrophobic amino acids at the carboxy terminus, consistent with a signal for GPI linkage; ephrin-A6b, g, d, and e are
redicted to be secreted ligands. The putative signal peptide sequence is underlined and the possible site of N-glycosylation is marked by
dotted overline. Amino acids and nucleotides are numbered at right. Amino acids that are different in the five ephrin-A6 variant forms
re boxed. Nucleotides that are present only in some forms are in shaded in gray, and 39 sequence common to all forms is underlined.
GenBank accession number AF317286. (C) PCR amplification is consistent with the presence of different ephrin-A6 transcripts in E8 retina.
mRNA from E8 retina was reverse transcribed and primers corresponding to 59 and 39 sequences of ephrin-A6 were used for amplification.
Two fragments were obtained (larger fragment and smaller fragment) and portions of each fragment were reamplified with three sets of
primers. Amplification products corresponding to the 59 end (lanes 2 and 5) and the middle portion (lanes 1 and 4) were the same, whereas
amplification products corresponding to the 39 end (lanes 3 and 6) were different, indicating that the two bands contain the same 59 region
and differ in their 39 regions. (D) Alignment of ephrin-A6 with the other ephrin-A ligands. The program CLUSTAL W was used for the
alignment. Amino acids that are identical in ephrin-A6 and in at least one of the other ligands are shaded in gray; cysteines are shaded in
black. Arrows indicate the positions where an intron has been identified in at least one of the ephrins; the amino acids corresponding to
the position of identified introns are underlined. An arrow with a question mark indicates the position where the four variant forms of
ephrin-A6 diverge. (E) Tree showing the relationship of ephrin-A6 with the other known ephrins. Chicken ephrin-A2, ephrin-A5, ephrin-B1,
and ephrin-B2 are compared to the corresponding mouse ephrins, to show that the chicken and mouse counterparts of the same ephrin are
much more closely related than ephrin-A6 is to any of the other ligands. Ephrin-A6, therefore, does not appear to be the chicken homolog
of a previously identified mammalian ephrin. c., chicken; m., mouse; and h., human.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
Con
79Ephrin-A6, A New Ligand for EphA Receptorsseveral amino acids at the beginning of the signal peptide
(which are not part of the mature protein) (Fig. 2B). By 39
FIG. 2—RACE we obtained several 39 sequences that differ in the
Copyright © 2001 by Academic Press. All rightnumber of nucleotides comprising a poly-C stretch. These
sequences are predicted to encode secreted proteins that
tinueddiffer in their most carboxy-terminal amino acids (ephrin-




the left in the pictures of nasal retina. The nerve fiber layer is the
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Copyright © 2001 by Academic Press. All rightA6b, g, d, and e in Fig. 2B). To obtain a cDNA containing
both 59 and 39 sequences, we performed RT-PCR using E8
retina mRNA as a template and primers corresponding to 59
and 39 sequences obtained by RACE. The PCR reaction
yielded two bands: a smaller one of the expected size of
approximately 400 bp, and a larger one of approximately
1000 bp (Fig. 2C). Additional PCR amplifications with
internal primers and sequence analysis showed that the two
bands contain the same 59 region but different 39 regions.
he 1000-bp band encodes a longer form that contains a
utative hydrophobic signal for GPI linkage at the
-terminus (ephrin-A6a in Fig. 2B), consistent with the
sequence of an ephrin of the A subclass. Interestingly, all
four variant forms diverge in the same region, suggesting
that they originate by alternative splicing. In agreement
with this hypothesis, an intron has been identified in the
corresponding region of ephrin-A2, ephrin-A3, and
ephrin-A5 (arrows in Fig. 2D). An alignment of the new
sequence with those of the five known A-ephrins (Fig. 2D)
and a phylogenetic tree (Fig. 2E) do not show a particularly
close similarity between the new sequence and any of the
other ephrins. This is consistent with the sequence encod-
ing a novel ephrin and not the chicken homolog of a
previously known one. We designated the new ephrin,
ephrin-A6, according to the guidelines of the Eph Nomen-
clature Committee (Eph Nomenclature Committee, 1997).
Ephrin-A6 Expression Is High in the Nasal Retina
and Low in the Optic Tectum, a Distribution
Distinct from That of Ephrin-A5
To examine the distribution of ephrin-A6 in the chicken
visual system, we prepared anti-ephrin-A6 polyclonal anti-
bodies. These antibodies do not recognize ephrin-A5 in
immunoblotting and immunoprecipitation experiments
(data not shown). Conversely, our anti-ephrin-A5 poly-
clonal antibodies do not recognize ephrin-A6. In sagittal
sections of E8 chicken heads, ephrin-A6 immunoreactivity
is most prominent in the nasal retina (Fig. 3A). Ephrin-A6 is
evenly distributed throughout the retinal layers including
the nerve fiber layer, which contains the axons of retinal
ganglion cells (Fig. 3B). In contrast, in the optic tectum
ephrin-A6 immunoreactivity is very faint (Fig. 3A). Thus, at
E8 ephrin-A5 and ephrin-A6 have a complementary pattern
of expression, with ephrin-A5 highly expressed in the
posterior tectum and ephrin-A6 highly expressed in the
topmost layer, which is mostly brown because it is devoid of cell
bodies. The pigmented epithelium (black) is at the bottom. (C)
Developmental regulation of ephrin-A5 and ephrin-A6 in embry-
onic chicken retina and tectum. Anti-ephrin-A6 and anti-
ephrin-A5 antibodies were used to immunoprecipitate the proteins
from equal amounts of protein extracts from the retina (R) and the
tectum (T) at the days of embryonic development indicated. TheFIG. 3. Ephrin-A6 is highly expressed in the developing E8
chicken nasal retina and poorly expressed in the optic tectum. (A)
Immunoperoxidase labeling shows high expression of ephrin-A6 in
the nasal retina (nr) and not in the temporal retina (tr) or the optic
tectum. The section was lightly counterstained with methyl green.
pt, posterior tectum; at, anterior tectum; of, optic fissure, which
separates nasal and temporal retina. (B) Ephrin-A6 is highly ex-
pressed throughout the layers of the nasal retina. Sagittal sections
similar to those in A, but at higher magnification, are shown. The
optic fissure is at the right in the pictures of temporal retina and atpositions of molecular weight standards, in Kd, are indicated at left.
s of reproduction in any form reserved.
E81Ephrin-A6, A New Ligand for EphA Receptorsnasal retina. Indeed, at all developmental stages examined
by immunoblotting, ephrin-A5 is predominantly expressed
in the optic tectum rather than the retina, whereas
ephrin-A6 is predominantly expressed in the retina (Fig.
3C). Interestingly, the developmental regulation of
ephrin-A6 protein expression in the visual system follows a
time course similar to that of ephrin-A5. Both ligands are
present at high levels at E6 and E8, when retinal axons are
growing toward their tectal targets (Goldberg, 1974).
Ephrin-A5 and ephrin-A6 expression gradually decreases at
later developmental stages and by E18, when retinotectal
topography has been established, their expression is barely
detectable.
Ephrin-A6 Is a High-Affinity Ligand for EphA4
To gather clues on the receptor binding properties of
ephrin-A6, we stained whole E3 chicken embryos with an
ephrin-A6 alkaline phosphatase fusion protein
(ephrin-A6 AP). Rhombomeres 3 and 5 were prominently
labeled (Fig. 4A). This result suggests that ephrin-A6 is a
high-affinity ligand for EphA4, the Eph receptor known to
be concentrated in rhombomeres 3 and 5 (Nieto et al.,
1992). This initial observation was confirmed in pull-
down experiments with an ephrin-A6 Fc fusion protein
(Fig. 4B). Among the different Eph receptors present in E8
chicken retinal extracts, ephrin-A6 Fc bound EphA4 and
also EphA3, but not EphB5. In comparison with ephrin-
A6, ephrin-A5 Fc bound similar amounts of EphA4 and
higher amounts of EphA3. To determine the affinity of
ephrin-A6 for different EphA receptors, we performed
equilibrium binding assays (Fig. 5). In these assays, dif-
ferent concentrations of ephrin-A6 AP were incubated
with EphA receptor Fc fusion proteins immobilized on
ELISA plates coated with anti-Fc antibodies. The appar-
ent dissociation constants (KD) measured in these experi-
ments for the binding of ephrin-A6 to chicken and mouse
EphA4 were 9.5 3 10210 and 7.9 3 10210 M, as expected for
high-affinity interactions. In comparison, the KD for the
binding of ephrin-A5 to EphA4 was 11 3 10210 M.
phrin-A6 also exhibited high binding affinities (low KD
values) for other EphA receptors that are expressed in the
visual system, including EphA3, EphA5, EphA7, and
EphA8, suggesting that ephrin-A6 may be a physiological
ligand for some of these receptors. Ephrin-A6 exhibited a
lower affinity for EphA6 (KD 5 46 3 1029 M) and
substantially lower but appreciable affinity for EphB2 (KD
5 146 3 1028 M). Overall, the binding affinities of
ephrin-A6 for different Eph receptors appeared similar to
those of ephrin-A5 (Fig. 5).
In agreement with the affinity measurements, ephrin-A6
Fc caused increased phosphorylation on tyrosine of both
EphA3 and EphA4 in cultures of retinal neurons (Fig. 6).
This result confirmed that ephrin-A6 is an activating ligand
for these EphA receptors. At the same concentration,
ephrin-A6 Fc did not detectably activate EphB2 and EphB5.
In an in vitro functional assay with retinal explants,
Copyright © 2001 by Academic Press. All rightephrin-A6 Fc added to the cultures caused collapse of both
temporal and nasal growth cones (Fig. 7). The percentage of
collapsed growth cones was much higher in temporal (78%)
than nasal (19%) growth cones, in agreement with the
reported lower sensitivity of nasal axons for ephrin-A li-
FIG. 4. Ephrin-A6 binds EphA receptors. (A) Whole-mount
labeling of an E3 chicken embryo with ephrin-A6 AP. Staining
(dark purple) is prominent in rhombomeres 3 and 5, where the
EphA4 receptor is concentrated, suggesting that ephrin-A6 binds
EphA4 with high affinity. ov, otic vesicle; 3, rhombomere 3; 5,
rhombomere 5. (B) Immunoprecipitations with ephrin Fc fusion
proteins incubated with E8 retina lysates. Equal amounts of the
indicated ephrin Fc fusion proteins, or the unfused Fc portion of
human IgG1 (Fc), were used for the immunoprecipitations.
EphA3, EphA4, or EphB5 remaining associated with the ephrin
Fc fusion proteins were detected by immunoblotting with anti-
bodies specific for each receptor. For comparison, retina lysates
run in the same gel were also probed with the antireceptor
antibodies. Ephrin-A6 and ephrin-A5 bound similar amounts of
EphA4, whereas ephrin-A5 bound higher amounts of EphA3 than
ephrin-A6. The positions of molecular weight standards, in Kd,
are indicated at left.gands.
s of reproduction in any form reserved.
82 Menzel et al.FIG. 5. Ephrin-A6 binds with high affinity to EphA receptors expressed in the visual system. (A) Representative binding curves and
corresponding Scatchard plots for the binding of ephrin-A6 AP to EphA receptors and to EphB2. (B) Summary of apparent KD values for the
binding of ephrin-A6 and ephrin-A5 to EphA receptors and to EphB2. The values shown are averages of KD values calculated by nonlinear
regression analysis of binding curves similar to those shown in (A). Apparent KD values are indicated in the table below, the number of
binding experiments (n) used to calculate each KD is indicated in parentheses, and error bars represent standard errors.































83Ephrin-A6, A New Ligand for EphA ReceptorsDISCUSSION
Ephrin-A ligands have been implicated in the formation
of various axonal projections, including the retinotectal
(Cheng and Flanagan, 1994; Drescher et al., 1995; Feldheim
et al., 2000, 1998; Frisen et al., 1998; Nakamoto et al.,
996), hippocamposeptal (Gao et al., 1996; Zhang et al.,
996), enthorinohippocampal (Stein et al., 1999), and
halamocortical (Gao et al., 1998) projections. They have
lso been proposed to regulate boundary formation between
indbrain segments (Xu et al., 1995); demarcation of bound-
ries and Purkinje cell compartments in the developing
erebellum (Karam et al., 2000; Rogers et al., 1999); forma-
ion of functional domains, layers, and circuits in the
eveloping cortex (Castellani et al., 1998; Donohue and
akic, 1999); and pathfinding of motor axons (Eberhart et
l., 2000; Kury et al., 2000).
We have identified a new ephrin, ephrin-A6, which is
ighly expressed in the chicken embryonic nasal retina.
onsistent with playing a role in the developing visual
ystem, ephrin-A6 activates EphA receptors and causes
rowth cone collapse in cultured retinal neurons. Among
he other five ephrins of the A subgroup, only ephrin-A2
nd ephrin-A5 have been detected in the visual system
Cheng et al., 1995; Drescher et al., 1995; Feldheim et al.,
2000). Ephrin-A2 and ephrin-A5 are the two most closely
related ephrins (Fig. 2D), have partially overlapping distri-
butions in several neural structures (Cheng and Flanagan,
1994; Drescher et al., 1995; Monschau et al., 1997; Zhang et
FIG. 6. Ephrin-A6 activates both EphA3 and EphA4 in cultures o
or ephrin-A5 Fc for 15 min, after which the cells were lysed in
antireceptor antibodies, or nonimmune rabbit Ig. The immunopre
upper panel), to monitor changes in receptor phosphorylation and
receptors (lower panel). IP, immunoprecipitating antibody; IB, imm
Kd, are indicated at left.al., 1996), and have redundant functions (Feldheim et al.,
Copyright © 2001 by Academic Press. All right998). Ephrin-A6, on the other hand, does not have espe-
ially high homology with ephrin-A2 or ephrin-A5 and has
distinctive expression pattern in the embryonic visual
ystem. While ephrin-A2 and ephrin-A5 are predominantly
xpressed in the optic tectum, ephrin-A6 is predominantly
xpressed in retinal cells, including the axons of retinal
anglion cells. The differences between ephrin-A6 and
phrin-A2/A5 in amino acid sequence, expression patterns,
eceptor binding properties, and secreted versus cell
urface-associated forms, suggest that ephrin-A6 has a role
uite distinct from those proposed for ephrin-A2 and
phrin-A5.
Ephrins in the Retina Regulate Retinotectal
Topography
Ephrin-A2 and ephrin-A5 expressed in the chicken optic
tectum and in a region ventrocaudal to the optic chiasm
control the topographic mapping of incoming retinal gan-
glion cell axons, presumably by activating a combination of
EphA receptors present on the surface of these axons
(Drescher, 1997; Flanagan and Vanderhaeghen, 1998; Mar-
cus et al., 2000; O’Leary and Wilkinson, 1999). EphA
receptors expressed in nasal retinal cells, however, appear
to be also regulated by ephrin-A ligands that are coex-
pressed in the retinal cells (Dutting et al., 1999; Feldheim et
al., 2000; Hornberger et al., 1999). It has been suggested that
by causing constitutive EphA receptor activation, ephrin-A
ligands present on the axons of nasal retinal ganglion cells
nal cells. Dissociated retinal cells were treated with ephrin-A6 Fc,
A buffer and used for immunoprecipitations with the indicated
tes were then probed with anti-phosphotyrosine antibodies (Ptyr,
vation, and reprobed with antibodies to the immunoprecipitated




unobrender these axons less sensitive to the ephrin repellent
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e84 Menzel et al.cues present on the posterior tectal surface and near the
optic chiasm (Connor et al., 1998; Dutting et al., 1999;
Hornberger et al., 1999; Marcus et al., 2000). Several pieces
of evidence substantiate this model. First, EphA4, a recep-
tor highly and uniformly expressed in the retina, is phos-
phorylated on tyrosine in the nasal retina, presumably
because it is activated by coexpressed ephrin-A ligands
(Connor et al., 1998). Second, in vitro stripe assay experi-
ments have shown that retinal axons exposed for prolonged
periods to activating ephrin-A ligands become less respon-
sive to ephrin-A guidance cues (Ciossek et al., 1998).
Similarly, axons grown on substrates uniformly coated with
A-ephrins seem to undergo adaptation to these ligands and
only respond to correspondingly higher concentrations of
ephrin repellent cues (Rosentreter et al., 1998). Third,
retrovirus-mediated overexpression of ephrin-A ligands in
retinal cells decreases the responsiveness of temporal axons
FIG. 7. Ephrin A6 induces collapse of retinal growth cones. (A)
Percentages of collapsed growth cones in cultures of temporal and
nasal retinal explants, following addition of 1 mg/ml clustered
phrin-A6-Fc or human Fc. Values represent the mean 6 SEM from
7 explants (ephrin-A6 Fc, temporal); 7 explants (Fc, temporal); 6
explants (ephrin-A6 Fc, nasal); and 4 explants (Fc, nasal). (B) Growth
cones from temporal retinal explants following addition of 1 mg/ml
ephrin-A6-Fc or 1 mg/ml human Fc.to ephrin-A repellent cues both in stripe assays and in vivo,
Copyright © 2001 by Academic Press. All rightin the optic tectum (Dutting et al., 1999; Hornberger et al.,
1999). Furthermore, the guidance defects observed after
ephrin misexpression correlate with aberrant tyrosine phos-
phorylation of the EphA4 receptor in the temporal retina.
Fourth, removal of GPI-linked proteins, including
A-ephrins, by cleavage with a phospholipase makes nasal
axons much more responsive to ephrin guidance cues in in
vitro stripe assays (Hornberger et al., 1999). Taken together,
these results strongly suggest that one or more ephrin-A
ligands expressed in nasal retinal cells influence topo-
graphic targeting of nasal retinal ganglion cell axons. The
ephrins involved, however, have not been unequivocally
identified. We propose here that ephrin-A6 is responsible
for a significant portion of the activities attributed to
ephrin-A ligands in chicken nasal retinal cells.
Ephrin-A6 and Retinotectal Topography
Several properties of ephrin-A6 point to a likely role as a
mainly retinal expressed molecule that could, however,
influence the growth of retinal fibers in the optic tectum.
First, ephrin-A6 is preferentially expressed in the retina and
its binding affinities for different Eph receptors are high and
similar to those of ephrin-A5. Ephrin-A2 and ephrin-A5
have also been detected in the nasal retina and in the axons
of nasal retinal ganglion cells (Brennan et al., 1997; Connor
et al., 1998; Dutting et al., 1999; Hornberger et al., 1999),
but these ephrins are expressed at much lower levels in the
chicken embryonic retina than in the tectum (Fig. 3C)
(Monschau et al., 1997). In fact, the expression level of
ephrin-A5 in the chicken retina declines to low levels
before the retinotectal projection is established (Fig. 3)
[(Dutting et al., 1999) and our unpublished data].
Second, we have detected ephrin-A6 in the nerve fiber
layer of the E8 chicken retina, where the axons of retinal
ganglion cells are located. Hence, ephrin-A6 could influ-
ence the behavior of nasal retinal axons. The time course of
ephrin-A6 expression in the retina parallels that of
ephrin-A5 expression in the tectum: both ligands are highly
expressed at E6, when retinal axons begin to grow on the
tectal surface. Their expression remains substantial during
the establishment of the retinotectal projection (E8 to E12)
and drastically declines at the later developmental stages.
This expression pattern is consistent with ephrin-A6 play-
ing a role in the regulation of retinotectal topography.
Third, in contrast to ephrin-A5, ephrin-A6 is strongly
expressed throughout nasal retina and the boundary be-
tween high and low expression of ephrin-A6 in the retina
coincides with the location of the optic fissure. Interest-
ingly, in stripe assays there is a step transition in correspon-
dence of the optic fissure between the responses of nasal
and temporal retinal axons to membrane-bound tectal guid-
ance cues (Rosentreter et al., 1998). Axons from areas just
posterior to the optic fissure avoid stripes of posterior tectal
membranes while axons just anterior to it are essentially
insensitive to such cues even though they express EphA4
receptor. Hence, the pattern of expression of ephrin-A6 is




























85Ephrin-A6, A New Ligand for EphA Receptorsconsistent with a role in modifying the guidance behaviors
of nasal versus temporal retinal axons in the stripe assays
and in vivo (Feldheim et al., 2000). In addition, our growth
cone collapse experiments demonstrate that ephrin-A6 can
indeed influence the behavior of retinal axons.
It is not known if ephrin-A6 has similar high expression
in the mouse retina as in the chicken retina, but this
appears likely. Labeling with EphA3 Fc or EphA5 Fc probes
suggested that ephrin-A ligands are present in the mouse
nasal retina (Feldheim et al., 2000; Marcus et al., 1996).
Ephrin-A5 mRNA was detected in the embryonic mouse
retina, but the level of expression appeared to be low and
confined to the extreme nasal retina. Interestingly, nasal
retinal axons from ephrin-A2/ephrin-A5 double knock out
mice remain less sensitive than temporal axons to wild-
type striped posterior tectal membranes (Feldheim et al.,
000), unlike axons of chicken nasal retina when deprived
f GPI-linked molecules (Hornberger et al., 1999). Retinal
xons of these knock out mice also retain some degree of
nterior–posterior topographic organization in vivo (Feld-
eim et al., 2000). An explanation for both these observa-
ions could be that a third ephrin-A ligand, such as ephrin-
6, is still present in the visual system of the ephrin-A2/
phrin-A5 double knock out mice. As described above,
phrin-A6 may play a role in nasal retinal cells by increas-
ng the basal levels of constitutive activation of the coex-
ressed Eph receptors. Ephrin-A6, however, may also act as
receptor-like molecule that transduces signals. Although
his role of the A-ephrins is not yet well understood, signals
ediated by GPI-linked ephrins have been shown to affect
ell adhesion and movement (Chin-Sang et al., 1999; Davy
t al., 1999; Wang et al., 1999).
Ephrin-A6 and Patterning of the Retina
The distribution of ephrin-A6 in the chicken retina is also
consistent with a role for this new ligand in the establish-
ment and/or stabilization of intraretinal organization along
the anterior–posterior axis. The complementary expression
of ephrin-A6 and EphA3, a receptor that is activated by
ephrin-A6, could contribute to keep nasal and temporal
retinal ganglion cells spatially separate. In fact, recent work
has shown that in rhombomeres of the hindbrain adjacent
populations of Eph receptor and ephrin expressing cells are
prevented from intermingling by the repulsive signals gen-
erated upon receptor-ligand interaction (Mellitzer et al.,
1999; Xu et al., 1999). In addition, unlike ephrin-A2 and
ephrin-A5, which are confined to the nerve fiber layer (Fig.
3B and Hornberger et al., 1999), ephrin-A6 is expressed in
ll layers of the E8 nasal retina and, therefore, can influ-
nces the behaviors of other types of cells in the retina in
ddition to retinal ganglion cells. Because ephrin-A6 exhib-
ts extensive overlap with EphA4, which is also expressed
hroughout the layers of the nasal retina at E6–E8 (Holash
nd Pasquale, 1995), ephrin-A6 expression in the retina
roduces two populations of retinal cells: a nasal population
ontaining activated EphA4 and a temporal population
Copyright © 2001 by Academic Press. All rightontaining inactive EphA4. The functional consequences of
his pattern of EphA4 tyrosine phosphorylation in retina
rganization, however, remain to be determined.
Soluble Ephrin-A6
We have detected mRNAs encoding putative secreted
forms of ephrin-A6 in the E8 chicken retina. Hence, in
addition to GPI-linked ephrin-A6, secreted forms of this
ligand may be produced as a result of gene splicing. Soluble
forms of other ephrins have been previously detected in cell
culture but presumably they are released from the cell
surface through cleavage by proteases or phospholipases
(Bartley et al., 1994; Bohme et al., 1996). Recent data have
indeed shown that ephrin-A2 is cleaved from the cell
surface by a metalloprotease activated following Eph recep-
tor -ephrin interaction (Hattori et al., 2000). Secreted forms
of ephrin-A6 could contribute to make retinal cells less
responsive to ephrin guidance cues. In in vitro stripe assays,
for example, monomeric ephrin-A2 added to the culture
medium inhibited retinal axon guidance without activating
Eph receptors (Ciossek et al., 1998). Monomeric ephrin-A6
may also decrease the degree of receptor clustering induced
by GPI-linked ephrins, which may change the effects of Eph
receptor activation on integrin-mediated cell adhesion
(Stein et al., 1998). Antibodies that distinguish GPI-linked
and soluble ephrin-A6 will be required to determine the
relative levels of expression, distribution, and developmen-
tal regulation of these different forms.
Three Ephrin-A Genes Are Differentially Expressed
in the Visual System
As discussed above, recent studies have shown that
ephrin-A ligands have important functions in both the
retina and the optic tectum. Here we show that at least
three different ephrin-A genes are preferentially expressed
in either the chicken retina or the tectum. Why is
ephrin-A6 preferentially expressed in the retina and ephrin-
A2/ephrin-A5 in the tectum, rather than the same genes
being expressed in both structures? There are several pos-
sible reasons. First, the three ephrins may interact differ-
ently with the Eph receptors expressed in the visual system.
Ephrin-A2 has been reported to bind to several EphA
receptors with lower affinity than ephrin-A5 (Flanagan and
Vanderhaeghen, 1998). In binding assays ephrin-A6 appears
to have overall Eph receptor binding properties similar to
those of ephrin-A5 but subtle differences between the Eph
receptor binding specificities of ephrin-A5 and ephrin-A6
may exist and result in significantly different biological
activities. Interestingly, differences in Eph receptor binding
were observed when ephrin-A5 Fc and ephrin-A6 Fc were
incubated with chicken retinal extracts. When competing
for binding with the other Eph receptors present in retinal
extracts, EphA3 associated more efficiently with ephrin-A5
than ephrin-A6. Second, secreted forms of ephrin-A ligands,
such as the secreted forms of ephrin-A6, may be required in
s of reproduction in any form reserved.
a86 Menzel et al.the retina but not the tectum. Third, differentially regulat-
ing the spatial and temporal expression of several ephrin-A
genes can yield complex ephrin-A expression patterns,
which may be required for visual system patterning. Several
pieces of evidence point to such complex spatial and tem-
poral regulation of ephrins in the visual system (Cheng et
l., 1995; Connor et al., 1998; Drescher et al., 1995; Dutting
et al., 1999; Feldheim et al., 2000; Marcus et al., 1996,
2000). Fourth, even though A-ephrins expressed both on
retinal axons and on tectal cells regulate formation of topo-
graphic maps, it may nevertheless be necessary to have
different ephrin genes that are placed under different genetic
control mechanisms in the retina versus the tectum. The
existence of several A-ephrins that are differentially expressed
in the visual system might have the advantage that they could
be independently regulated by different transcription factors,
affording more flexibility in the control of their expression in
projecting (e.g., retina) versus target (e.g., tectum) regions.
In conclusion, ephrin-A6 is the newest member of the
ephrin family, and our data suggest that it plays a distinctive
role in the topographic organization of the visual system. As
the families of molecules expressed in retinal and tectal cells,
and along the visual pathway, continue to be identified, it
becomes clear that complex signaling and adhesive interac-
tions between nerve fibers and cells as well as between nerve
fibers themselves are required to provide the sophisticated
regulation necessary for visual structures to assemble. It will
be important to determine the contribution of ephrin-A6 to
this process. In addition, future studies will reveal whether
ephrin-A6 is expressed outside the visual system and is
required for the development of certain neural structures.
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